SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is facing a sharp price correction and significant liquidations, driving heated community discussion with many critics intensifying 'scam' allegations and some linking the downturn to the recently released Epstein files. Despite the FUD, long-term holders are embracing the dip as a prime accumulation opportunity, confident in its cyclical recovery.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending sharply downward, with the community questioning why it's falling harder than other cryptos amidst broader market weakness, fueling fears of a prolonged crash and discussions around alleged institutional manipulation and regulatory uncertainties like the Clarity Act.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is trending as its earnings call approaches, coinciding with a significant drop in Bitcoin's price that has amplified community concerns over substantial unrealized losses on its BTC holdings. Many investors are highly critical of Michael Saylor's strategy, with discussions widespread about potential liquidation and the stock's future given its role as a Bitcoin proxy.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon.com Inc is trending as investors eagerly await its earnings report, with community sentiment divided on whether strong AWS performance and recent AI developments can drive a rally, or if concerns about capital expenditures, similar to those affecting other tech giants, will lead to a sell-off.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending after posting a surprise Q4 profit, revenue beat, and announcing a new stock buyback, yet the stock experienced a sharp decline, sparking intense community discussion about market manipulation versus concerns over future guidance and leadership.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending following its Q4 earnings beat, where strong Search and Cloud growth were overshadowed by a projected near-doubling of 2026 capital expenditures for AI infrastructure. While the community is debating whether this massive investment signals confident AI leadership or potential margin pressure, many are highlighting Google's strong balance sheet and commitment to competitive positioning.

Kelly Services, Inc. engages in the provision of talent solutions. It operates through the following segments: Professional and Industrial, Science, Engineering, and Technology, Education, Outsourcing and Consulting, and International. The Professional and Industrial segment includes the provision of administrative, accounting and finance, light industrial, contact center staffing, and other workforce solutions. The Science, Engineering, and Technology segment focuses on staffing, outcome-based, permanent placement services, clinical research, and telecommunications. The Education segment involves offering education and therapy services talent through staffing, permanent placement, and executive search services to Pre-K-12 school districts and organizations. The Outsourcing and Consulting segment consists of global talent supply chain and workforce solutions, including Managed Service Provider (MSP), Recruitment Process Outsourcing (RPO), Payroll Process Outsourcing (PPO), and executive coaching programs. The company was founded by William Russell Kelly on October 7, 1946 and is headquartered in Troy, MI.

Kelly Services, Inc. - Ordinary Shares - Class B

Kelly Services Class B shares ($KELYB) are exhibiting extreme volatility and massive price surges, largely attributed to its ultra-low public float and high insider ownership following Hunt Equity Opportunities' acquisition of a controlling stake. The community is actively debating if this constitutes a short squeeze or a pump-and-dump, while observing its frequent trading halts and the comparative lack of movement in its Class A shares ($KELYA).

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is facing significant selling pressure amid broader crypto market weakness and regulatory uncertainty following a White House meeting on crypto market structure, further compounded by a Nevada Gaming Control Board filing, leading to widespread investor debate over whether the deeply oversold stock has found a bottom.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is actively discussed after launching a low-cost, compounded semaglutide pill and a multi-cancer detection test, immediately sparking legal threats from Novo Nordisk; investors are sharply divided between anticipating massive market disruption and significant regulatory and litigation risks.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing significant selling pressure driven by disappointing labor data, broad European market declines, and growing concerns about tech sector valuations and AI investments. The community is sharply divided, debating whether current price action represents a 'dead cat bounce' or a buying opportunity, with widespread discussion on key support levels and options strategies amid this market volatility.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Director Sells 12,528 Shares of Stock

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) Director Barry Quart sold 12,528 shares of Kiniksa Pharmaceuticals International stock in a transaction that occurred on...

Universal Beteiligungs und Servicegesellschaft mbH Acquires 51,204 Shares of Kiniksa Pharmaceuticals International, plc $KNSA

Universal Beteiligungs und Servicegesellschaft mbH grew its holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 560.2% in the 3rd quarter, according to its most...

Campbell & CO Investment Adviser LLC Makes New $1.48 Million Investment in Kiniksa Pharmaceuticals International, plc $KNSA

Campbell & CO Investment Adviser LLC bought a new stake in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) in the third quarter, according to its most recent...

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) have earned an average recommendation of "Moderate Buy" from the eight research firms that are presently covering...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Lowered to Strong Sell Rating by Zacks Research

Zacks Research cut Kiniksa Pharmaceuticals International from a "hold" rating to a "strong sell" rating in a research report on Tuesday...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CFO Sells $502,680.00 in Stock

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) CFO Mark Ragosa sold 12,000 shares of the stock in a transaction dated Thursday, January 8th. The shares were sold at an...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Down 6.2% - Here's What Happened

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Down 6.2% - Time to Sell...

Rice Hall James & Associates LLC Reduces Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA

Rice Hall James & Associates LLC lowered its position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 9.5% during the third quarter, according to the company in its most...

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of "Moderate Buy" by Analysts

Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eight research firms that are currently covering...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells $500,714.88 in Stock

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) COO Eben Tessari sold 12,048 shares of the stock in a transaction that occurred on Monday, December 15th. The stock was sold...

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $AMZN earnings on Thursday?

KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KNSA News

KNSAKiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A